CAM
MDT icon

Cresset Asset Management’s Medtronic MDT Stock Holding History

Cresset Asset Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-50,000
Closed -$4.41M – 1912
2023
Q2 		$4.41M Buy
+50,000
New +$4.3M 0.01% 446

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cresset Asset Management's MDT Position: Q1 2026 in Review

Cresset Asset Management increased its Medtronic (MDT) stake by 14% in Q1 2026, buying an estimated $2.37M and bringing the position to 199,626 shares worth $17.4M. The position accounts for 0.08% of the portfolio, ranked #174.

Cresset Asset Management first reported a position in MDT in Q4 2018 and has held it in 30 quarters since. The position peaked at $30.4M in Q3 2024. 2,237 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Cresset Asset Management held 199,626 shares of Medtronic worth $17.4M as of Q1 2026.
  • Cresset Asset Management bought 24,747 Medtronic shares in Q1 2026, an estimated $2.37M.
  • Medtronic made up 0.08% of Cresset Asset Management's portfolio in Q1 2026, its #174 holding.
  • Cresset Asset Management first reported a position in Medtronic in Q4 2018 and has held it in 30 quarters since.
  • Cresset Asset Management's Medtronic position peaked at $30.4M in Q3 2024.
  • 2,237 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Cresset Asset Management's 13F filing for Q1 2026, filed 15 May 2026.